Tymon Pol

The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF): Rationale and design

Lund, Lars H; James, Stefan; DeVore, Adam D; Anstrom, Kevin J et al.

Ingår i European Journal of Heart Failure, s. 2453-2463, 2024

• DOI för The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF): Rationale and design
• Ladda ner fulltext (pdf) av The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF): Rationale and design

Novel biomarkers and their relation to clinical outcomes and pathophysiology in anticoagulated patients with atrial fibrillation

Pol, Tymon

2024

• Ladda ner fulltext (pdf) av Novel biomarkers and their relation to clinical outcomes and pathophysiology in anticoagulated patients with atrial fibrillation

Heart failure registries - Future directions

Pol, Tymon; Karlström, Patric; Lund, Lars H.

Ingår i Journal of Cardiology, s. 84-90, 2024

• DOI för Heart failure registries - Future directions

Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation.

Pol, Tymon; Hijazi, Ziad; Lindbäck, Johan; Oldgren, Jonas et al.

Ingår i Cardiovascular Research, s. 2112-2123, 2021

• DOI för Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation.
• Ladda ner fulltext (pdf) av Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation.

Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation.

Siegbahn, Agneta; Lindbäck, Johan; Hijazi, Ziad; Åberg, Mikael et al.

Ingår i Journal of Thrombosis and Haemostasis, s. 2726-2737, 2021

• DOI för Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation.
• Ladda ner fulltext (pdf) av Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation.

The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF): Rationale and design

Lund, Lars H; James, Stefan; DeVore, Adam D; Anstrom, Kevin J et al.

Ingår i European Journal of Heart Failure, s. 2453-2463, 2024

• DOI för The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF): Rationale and design
• Ladda ner fulltext (pdf) av The Spironolactone Initiation Registry Randomized Interventional Trial in Heart Failure with Preserved Ejection Fraction (SPIRRIT-HFpEF): Rationale and design

Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation.

Pol, Tymon; Hijazi, Ziad; Lindbäck, Johan; Oldgren, Jonas et al.

Ingår i Cardiovascular Research, s. 2112-2123, 2021

• DOI för Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation.
• Ladda ner fulltext (pdf) av Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillation.

Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation.

Siegbahn, Agneta; Lindbäck, Johan; Hijazi, Ziad; Åberg, Mikael et al.

Ingår i Journal of Thrombosis and Haemostasis, s. 2726-2737, 2021

• DOI för Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation.
• Ladda ner fulltext (pdf) av Multiplex protein screening of biomarkers associated with major bleeding in patients with atrial fibrillation treated with oral anticoagulation.

Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas

Pol, Tymon; Hijazi, Ziad; Lindbäck, Johan; Alexander, John H. et al.

Ingår i Open heart, 2021

• DOI för Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas
• Ladda ner fulltext (pdf) av Evaluation of the prognostic value of GDF-15, ABC-AF-bleeding score and ABC-AF-death score in patients with atrial fibrillation across different geographical areas

Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.

Armstrong, Paul W; Pieske, Burkert; Anstrom, Kevin J; Ezekowitz, Justin et al.

Ingår i New England Journal of Medicine, s. 1883-1893, 2020

• DOI för Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction.

Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation

Hijazi, Ziad; Wallentin, Lars; Lindbäck, Johan; Alexander, John H. et al.

Ingår i Journal of the American Heart Association, 2020

• DOI för Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation
• Ladda ner fulltext (pdf) av Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation

New Biomarkers Associated With Cardiovascular Death In Patients With Atrial Fibrillation Using Multimarker Screening: Insights From The Aristotle Trial

Pol, Tymon; Hijazi, Ziad; Lindbäck, Johan; Oldgren, Jonas et al.

Ingår i Journal of the American College of Cardiology, s. 330-330, 2018

• DOI för New Biomarkers Associated With Cardiovascular Death In Patients With Atrial Fibrillation Using Multimarker Screening: Insights From The Aristotle Trial

Novel Prognostic Biomarkers For Ischemic Stroke In Patients With Atrial Fibrillation Using Multimarker Screening: Insights From The Aristotle Trial

Hijazi, Ziad; Pol, Tymon; Oldgren, Jonas; Lindbäck, Johan et al.

Ingår i Journal of the American College of Cardiology, s. 506-506, 2018

Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial

Pol, Tymon; Held, Claes; Westerbergh, Johan; Lindbäck, Johan et al.

Ingår i Journal of the American Heart Association, 2018

• DOI för Dyslipidemia and Risk of Cardiovascular Events in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Therapy: Insights From the ARISTOTLE (Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation) Trial

Heart failure registries - Future directions

Pol, Tymon; Karlström, Patric; Lund, Lars H.

Ingår i Journal of Cardiology, s. 84-90, 2024

• DOI för Heart failure registries - Future directions

Novel biomarkers and their relation to clinical outcomes and pathophysiology in anticoagulated patients with atrial fibrillation

Pol, Tymon

2024

• Ladda ner fulltext (pdf) av Novel biomarkers and their relation to clinical outcomes and pathophysiology in anticoagulated patients with atrial fibrillation

Screening of plasma biomarkers for heart failure hospitalizations and heart failure subtype in patients with atrial fibrillation

Pol, Tymon; Lindbäck, Johan; Oldgren, Jonas; Alexander, John H. et al.